Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DCL000838

Drug Information
NameIbudilast
SynonymsEU-0100599; I 0157; NCGC00025261-03; 1-Propanone, 2-methyl-1-(2-(1-methylethyl)pyrazolo(1,5-a)pyridin-3-yl)-; 2-Isopropyl-3-isobutyrylpyrazolo(1,5-a)pyridine; Bio-0127; Ibudilast (JAN/INN); Eyevinal; 1-(2-Isopropylpyrazolo(1,5-a)pyridin-3-yl)-2-methyl-1-propanone; CID3671; Ke Tas; CHEBI:123745; C038366; 2-methyl-1-(2-propan-2-ylpyrazolo[1,5-a]pyridin-3-yl)propan-1-one; I0157_SIGMA; NCGC00025261-02; AV-411; I0740; KC-404; NCGC00025261-01; KC 404; SMR000326961; Ibudilastum; Tocris-1694; 2-Methyl-1-[2-(1-methylethyl)pyrazolo[1,5-a]pyridin-3-yl] 1-propanone; DB05266; Ketas (TN); MN-166; 50847-11-5; NCGC00015542-06; Ibudilast [INN:JAN]; Lopac-I-0157; I06-0361; AC-1044; AV 411; Ibudilastum [Latin]; BRN 0656579; CHEMBL19449; ZINC00004234; ibudilast; D01385; Pyrazolo(1,5-a)pyridine, 3-isobutyryl-2-isopropyl-; NCGC00015542-03; 3-Isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine; BRD-K16444452-001-03-4; LS-129153; Lopac0_000599; UNII-M0TTH61XC5; 3-Isobutyryl-2-isopropylpyrazolo(1,5-a)pyridine; AC1L1GGB; L003042; Ketas; MolPort-003-848-127; 5-24-03-00396 (Beilstein Handbook Reference); HMS2089B21; NCGC00015542-01; MLS000862198
CompanyAvigen
IndicationOpioid-Related Disorders, Diabetic neuropathy
[ICD9: 250, 250.6, 292, 304.0, 305.50, 356.0, 356.8   ICD10: E08-E13, E10.4, E11.4, E13.4, F11, G64, G90.0]
Phase II    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C14H18N2O/c1-9(2)13-12(14(17)10(3)4)11-7-5-6-8-16(11)15-13/h5-
10H,1-4H3
InChIKeyZJVFLBOZORBYFE-UHFFFAOYSA-N
Canonical SMILESCC(C)C1=NN2C=CC=CC2=C1C(=O)C(C)C    
CAS NumberCAS 50847-11-5
PubChem Compound IDCID 3671.
PubChem Substance IDSID 213994.
SuperDrug ATC IDR03DC04
SuperDrug CAS ID050847115;
ClinicalTrials.govNCT00723177;
TargetInterleukin-1 betaInhibitor[1]
Interleukin-1 betaMultitarget[1]
Interleukin-6Inhibitor[1]
Interleukin-6Multitarget[1]
Ref 1Emerging drugs in neuropathic pain. Expert Opin Emerg Drugs. 2007 Mar;12(1):113-26. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543